Table 2.
Influence of NE challenge on induction of gut lesions, mortality rate, growth performance and the ameliorative effect of probiotics.
| Probiotic Strain | Response to NE Challenge | Response to Dietary Probiotics | Ref | |||||
|---|---|---|---|---|---|---|---|---|
| S/N | Lesion Site | Mortality Rate | GP | Lesion Site | Mortality Rate | GP | ||
| 1 | B. amyloliquefaciens CECT 5940 | Jejunum | Comparable to positive control | Reduced growth performance | No effect | Not significant | Improved performance | [11] |
| 2 | B. licheniformis H2 | NE | High mortality rate | Reduced growth performance | NE | Reduced mortality rate | Enhanced weight gain and reduced FCR | [12] |
| 3 | Multi strains of Lactobacillus | Small intestine | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Enhanced weight gain and reduced FCR | [13] |
| 4 | B. subtilis DSM29784 | Comparable to control | High mortality rate | Reduced growth performance | NE | Reduced mortality rate | Enhanced weight gain | [17] |
| 5 | B. subtilis | Jejunum and ileum | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Reduced FCR | [18] |
| 6 | B. licheniformis | Duodenum, jejunum and ileum | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Reduced FCR | [19] |
| 7 | Bacillus | Ileum | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Improved weight | [21] |
| 8 | B. licheniformis | Duodenum, jejunum and ileum | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Reduced FCR | [23] |
| 9 | B. coagulans | Duodenum and jejunum | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Enhanced weight gain and reduced FCR | [25] |
| 10 | Clostridium. butyricum | Intestine | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Reduced FCR | [26] |
| 11 | L. plantarum 1.2567 | Small intestine | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Improved weight gain | [30] |
| 12 | B. amyloliquefaciens H57. | Small intestine | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Enhanced weight gain and reduced FCR | [31] |
| 13 | B. subtilis | Duodenum, jejunum and ileum | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Reduced FCR | [32] |
| 14 | L. fermentum, B. coagulans | Duodenum and Ileum | High mortality rate | Reduced growth performance | no effect | Reduced mortality rate | Reduced FCR | [33] |
| 15 | B. subtilis DSM 32315. | NE | High mortality rate | Reduced growth performance | NE | Reduced mortality rate | [52] | |
| 16 | Multi strain | Duodenum, jejunum and ileum | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Reduced FCR | [53] |
| 17 | Lactobacillus johnsonii BS15 | NE | High mortality rate | Reduced growth performance | NE | Reduced mortality rate | Enhanced weight gain and reduced FCR | [70] |
| 18 | Primlac: multi strain | Duodenum and jejunum | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Reduced FCR | [94] |
| 19 | B. subtilis DSM29784 | Jejunum | High mortality rate | Reduced growth performance | Comparable to control | Reduced mortality rate | Enhanced weight gain and reduced FCR | [95] |
| 20 | B. licheniformis H2 | Ileum | High mortality rate | Reduced growth performance | NO | Reduced mortality rate | Enhanced weight gain and reduced FCR | [109] |
| 21 | B. amyloliquefaciens BLCC1-0238 | Duodenum | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Enhanced weight gain and reduced FCR | [110] |
| 22 | Multi strain | Duodenum, jejunum and ileum | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Enhanced weight gain and reduced FCR | [111] |
| 23 | E. faecium | Jejunum | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Enhanced weight gain and reduced FCR | [112] |
| 24 | B. subtilis DSM 32315 | Footpad | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Enhanced weight gain and reduced FCR | [113] |
| 25 | L. johnsonii BS15 | NE | High mortality rate | Reduced growth performance | NE | Reduced mortality rate | Enhanced weight gain and reduced FCR | [114] |
| 26 | C. butyricum MIYAIRI 588 | Small intestine | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Enhanced weight gain and reduced FCR | [115] |
| 27 | L. johnsonii BS15, Bacillus | NE | High mortality rate | Reduced growth performance | NE | Reduced mortality rate | Enhanced weight gain and reduced FCR | [116] |
| 28 |
B. subtilis DSM 32315 |
Mid intestine | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Enhanced weight gain and reduced FCR | [117] |
| 29 | Bacteriophage | Jejunum | High mortality rate | Reduced growth performance | Reduced lesion scores | Zero mortality in high-dose PRO group | Improved weight gain | [118] |
| 30 | Bacillus. Surfactin (fermented product) | Duodenum, jejunum and ileum | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Enhanced weight gain and reduced FCR | [119] |
| 31 | B. licheniformis | Duodenum and jejunum | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Enhanced weight gain and reduced FCR | [120] |
| 32 | Butyricicoccus pullicaecorum 25-3T | Duodenum and jejunum | High mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Reduced FCR | [121] |
| 33 | B. subtilis DSM29784 | Ileum | Low mortality rate | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | No effect | [122] |
| 34 | L. johnsonii. LB 15 | NE | High mortality rate | Reduced growth performance | NE | Reduced mortality rate | Enhanced weight gain and reduced FCR | [123] |
| 35 | B. amyloliquefaciens CECT 5940 | Footpad | Comparable to positive control | Reduced growth performance | Reduced lesion scores | Reduced mortality rate | Enhanced weight gain and reduced FCR | [124] |
NE-not evaluated, FCR-feed conversion ratio.